BIOS Fund II QP, LP — SEC insider filings

SEC reporting owner CIK 1716869. 33 insider filings on record with FilingPulse; latest filed 2026-10-30.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2021-08-03 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ACTUATE THERAPEUTICS, INC. (ACTU)Director, 10% owner53 legs · 571,428 sh · $4,499,9966 legs · 49,998 sh · $424,98365
Lantern Pharma Inc. (LTRN)10% owner9—62 legs · 892,532 sh · $3,686,52910
Azitra Inc (AZTR)10% owner16 legs · 2,297,490 sh · $3,000,0003 legs · 669,317 sh24
COGNITION THERAPEUTICS INC (CGTX)Director, 10% owner99 legs · 1,587,064 sh · $1,941,965—8
IN8BIO, INC. (INAB)10% owner921 legs · 252,429 sh · $539,628—24

Insider filings — BIOS Fund II QP, LP

FiledFormIssuerReported transactionsSource
2026-10-304ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with BIOS Fund I, LP, Bios 2024 Co-Invest, LP, BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LP, BIOS Fund I QP, LP, BIOS Fund II NT, LP, BIOS Fund II, LP
Grant/award (A): 64,995 (derivative) @ $0 · Grant/award (A): 87,743 (derivative) @ $0 · Grant/award (A): 682,885 (derivative) @ $0 · Grant/award (A): 194,984 (derivative) @ $0 · Grant/award (A): 368,304 (derivative) @ $0 · Grant/award (A): 47,972 (derivative) @ $0 · +7 moreEDGAR
2026-06-224COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP, BIOS Fund I QP, LP
Grant/award (A): 25,000 @ $0EDGAR
2025-06-304ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners II, LP
Purchase (P): 71,428 @ $7 · Purchase (P): 71,428 (derivative) @ $0EDGAR
2025-06-204COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Grant/award (A): 34,000 @ $0EDGAR
2025-06-134Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 3 @ $3.40 · Sale (S): 171 @ $3.40 · Sale (S): 10,925 @ $3.38 · Sale (S): 5 @ $3.40 · Sale (S): 293 @ $3.40 · Sale (S): 18,678 @ $3.38 · +9 moreEDGAR
2025-06-134Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 7,206 @ $3.09 · Sale (S): 12,319 @ $3.09 · Sale (S): 1,903 @ $3.09 · Sale (S): 14,218 @ $3.09 · Sale (S): 4,354 @ $3.09EDGAR
2025-05-294Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 3,790 @ $3.05 · Sale (S): 2,702 @ $2.87 · Sale (S): 3,639 @ $3.03 · Sale (S): 6,479 @ $3.05 · Sale (S): 4,620 @ $2.87 · Sale (S): 6,221 @ $3.03 · +9 moreEDGAR
2025-05-074IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, Bios Clinical Opportunity Fund, LP, Bios Equity COF, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 1,148,482 (derivative) · Other (J): 574,241 (derivative) · Other (J): 574,241 (derivative)EDGAR
2024-10-114IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, Bios Clinical Opportunity Fund, LP, Bios Equity COF, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 709,040 (derivative) · Purchase (P): 709,040 (derivative) · Disposition to issuer (D): 574,241 (derivative) · Grant/award (A): 574,241 (derivative)EDGAR
2024-08-204/AACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners II, LP
Sale (S): 5,314 @ $8 · Sale (S): 17,361 @ $8 · Sale (S): 2,324 @ $8EDGAR
2024-08-144ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners II, LP
Conversion (C): 884,427 · Purchase (P): 375,000 @ $8 · Purchase (P): 125,000 @ $8 · Conversion (C): 525,797 · Conversion (C): 307,538 · Conversion (C): 141,457 · +50 moreEDGAR
2024-08-144ACTUATE THERAPEUTICS, INC. (ACTU)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners II, LP
Holdings only — no transactions reportedEDGAR
2024-06-114COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Grant/award (A): 8,500 @ $0 · Grant/award (A): 8,500 (derivative) @ $0EDGAR
2024-05-284Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 930 @ $6.25 · Sale (S): 1,859 @ $6.33 · Sale (S): 6,944 @ $6.25 · Sale (S): 13,888 @ $6.33 · Sale (S): 2,126 @ $6.25 · Sale (S): 4,253 @ $6.33EDGAR
2024-02-294Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 4,649 @ $4.40 · Sale (S): 6,909 @ $4.85 · Sale (S): 1,832 @ $4.87 · Sale (S): 34,731 @ $4.40 · Sale (S): 51,608 @ $4.85 · Sale (S): 13,686 @ $4.87 · +3 moreEDGAR
2024-01-194Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Option exercise/expiry (X): 7,347 @ $3.13 · Sale (S): 5,475 @ $4.20 · Option exercise/expiry (X): 54,873 @ $3.13 · Sale (S): 40,893 @ $4.20 · Option exercise/expiry (X): 16,801 @ $3.13 · Sale (S): 12,521 @ $4.20 · +3 moreEDGAR
2023-12-144IN8BIO, INC.
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative) · Purchase (P): 574,241 (derivative)EDGAR
2023-12-014Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 53,640 @ $3.44 · Sale (S): 91,708 @ $3.44EDGAR
2023-11-134COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Grant/award (A): 500,095 @ $1.05EDGAR
2023-06-234Azitra Inc (AZTR)
jointly with Kreis Leslie W., Cavu Advisors, LLC, Cavu Management, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, Bios Equity Partners, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners II, LP
Sale (S): 77,953 · Purchase (P): 197,701 · Purchase (P): 69,880 @ $5 · Conversion (C): 137,186 · Sale (S): 509,141 · Purchase (P): 1,291,258 · +27 moreEDGAR
2023-06-134COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Grant/award (A): 6,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-134IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 9,214 @ $2.48 · Purchase (P): 57,052 @ $2.48 · Purchase (P): 8,735 @ $2.48EDGAR
2022-11-294COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Purchase (P): 1,973 @ $2.65 · Purchase (P): 12,220 @ $2.65 · Purchase (P): 1,871 @ $2.65EDGAR
2022-11-174COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Purchase (P): 8,722 @ $1.40 · Purchase (P): 54,009 @ $1.40 · Purchase (P): 8,269 @ $1.40EDGAR
2022-11-164COGNITION THERAPEUTICS INC (CGTX)
jointly with Fletcher Aaron G.L., BIOS Capital Management, LP, BIOS Advisors GP, LLC, Bios Equity Partners, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Memory SPV I, LP, Bios Equity Partners II, LP, BIOS Fund II, LP
Purchase (P): 184,270 @ $1.20 · Purchase (P): 1,141,030 @ $1.20 · Purchase (P): 174,700 @ $1.20EDGAR
2022-11-094Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Sale (S): 58,711 @ $4.40 · Sale (S): 100,380 @ $4.40 · Sale (S): 17,748 @ $4.40 · Sale (S): 132,575 @ $4.40 · Sale (S): 40,586 @ $4.40EDGAR
2022-09-294IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Incysus Co-Invest I, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Purchase (P): 3,070 @ $2.02 · Purchase (P): 19,017 @ $2.02 · Purchase (P): 2,913 @ $2.02EDGAR
2022-09-074Lantern Pharma Inc. (LTRN)
jointly with Fletcher Aaron G.L., BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, Bios Equity Partners, LP, Bios Equity Partners II, LP, BIOS Capital Management, LP, BIOS Advisors GP, LLC
Option exercise/expiry (X): 26,100 @ $1.03 · Sale (S): 5,170 @ $5.20 · Option exercise/expiry (X): 6,438 @ $1.03 · Sale (S): 1,275 @ $5.20 · Option exercise/expiry (X): 26,100 (derivative) @ $0 · Option exercise/expiry (X): 6,438 (derivative) @ $0EDGAR
2022-08-304IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 1,377 @ $2.01 · Purchase (P): 4,912 @ $2.02 · Purchase (P): 8,531 @ $2.01 · Purchase (P): 30,428 @ $2.02 · Purchase (P): 1,306 @ $2.01 · Purchase (P): 4,660 @ $2.02EDGAR
2022-08-304IN8BIO, INC. (INAB)
jointly with Fletcher Aaron G.L., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 1,377 @ $2.01 · Purchase (P): 4,912 @ $2.02 · Purchase (P): 8,531 @ $2.01 · Purchase (P): 30,428 @ $2.02 · Purchase (P): 1,306 @ $2.01 · Purchase (P): 4,660 @ $2.02EDGAR
2022-08-184IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC
Purchase (P): 6,142 @ $1.93 · Purchase (P): 38,035 @ $1.93 · Purchase (P): 5,823 @ $1.93EDGAR
2022-02-014/ACOGNITION THERAPEUTICS INC (CGTX)
jointly with BIOS Memory SPV I, LP, BIOS Fund I, LP, BIOS Fund I QP, LP, BIOS Fund II, LP, BIOS Fund II NT, LP, BIOS Memory SPV II, LP, BIOS Fund III, LP, BIOS Fund III QP, LP, BIOS Fund III NT, LP
Conversion (C): 1,424,014EDGAR
2021-08-034IN8BIO, INC. (INAB)
jointly with Kreis Leslie W., BIOS Fund II NT, LP, BIOS Fund II, LP, BIOS Incysus Co-Invest I, LP, Bios Equity Partners II, LP, BIOS Equity Partners III, LP, Cavu Management, LP, Cavu Advisors, LLC
Conversion (C): 574,432 · Conversion (C): 1,876,624 · Conversion (C): 251,211 · Conversion (C): 997,433 · Conversion (C): 340,712 · Conversion (C): 2,225,316 · +8 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2021-07-14 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1716869 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs